Management of Retinopathy of Prematurity in an African Population- An Analytical Retrospective Comparative Study

Francis Kwasi Obeng; Vipan Kumar Vig; Emmanuel Parbie Abbeyquaye; Preetam Singh; Rajbir Singh; Yin Baba Dennis

doi:10.34257/

Authors

Francis Kwasi Obeng
Vipan Kumar Vig
Emmanuel Parbie Abbeyquaye
Preetam Singh
Rajbir Singh
Yin Baba Dennis

Keywords:

retinal neovascularization, prematurity, childhood blindness, low birth weight, neonatal oxygen therapy

Abstract

Abstract not found

Downloads

Article PDF

How to Cite

Management of Retinopathy of Prematurity in an African Population- An Analytical Retrospective Comparative Study. (2022). Global Journal of Medical Research, 22(F7), 19-28. https://doi.org/10.34257/

Download Citation

References

Ameenat Solebo, Lucinda Teoh, Jugnoo Rahi (2017) Epidemiology of blindness in children. 102(9), 853-857.

C Ludwig (2017) Unknown Title. 48, 553-562.

Dupe Ademola-Popoola, Tunji Oluleye (2017) Retinopathy of Prematurity (ROP) in a Developing Economy with Improving Health Care. 5(2), 114-118.

Pia Lundgren, Elisabeth Stoltz Sjöström, Magnus Domellöf, Karin Källen, Gerd Holmström, Anna-Lena Hård, Lois Smith, Chatarina Löfqvist, Ann Hellström (2013) WINROP Identifies Severe Retinopathy of Prematurity at an Early Stage in a Nation-Based Cohort of Extremely Preterm Infants. 8(9), e73256.

Anuk Ince, D Gulcan, H Hanta, D (2013) Poor postnatal weight gain predicts stage 3+ retinopathy of prematurity in very low birth weight infants. 55(3), 304-308.

Alisse Hauspurg, Elizabeth Allred, Deborah Vanderveen, Minghua Chen, Francis Bednarek, Cynthia Cole, Richard Ehrenkranz, Alan Leviton, Olaf Dammann (2011) Blood Gases and Retinopathy of Prematurity: The ELGAN Study. 99(2), 104-111.

K Heidar (2020) Retinopathy of prematurity.

Ann Hellström, Lois Smith, Olaf Dammann (2013) Retinopathy of prematurity. 382(9902), 1445-1457.

Mayo Clinic (2020) 1 Premature Predicaments. 29-58.

Janaina Carvalho (2014) Hipotermia em recém-nascidos prematuros na admissão em uma unidade de terapia intensiva neonatal. 84.

R Moinho, S Morais, M Monteiro, G Mimoso (2015) Retinopathy of prematurity in a neonatal intensive care unit: experience of eight years. 46, 198-204.

Y Yonekawa (2017) The cutting edge of retinopathy of prematurity care.

Tailoi Chan-Ling, Glen Gole, Graham Quinn, Samuel Adamson, Brian Darlow (2018) Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective. 62, 77-119.

Lois Smith (2008) Through The Eyes of a Child: Understanding Retinopathy through ROP The Friedenwald Lecture. 49(12), 5177.

Min Zhao, Wan-Kun Xie, Yu-Jing Bai, Lyu-Zhen Huang, Bin Wang, Jian-Hong Liang, Hong Yin, Xiao-Xin Li, Xuan Shi (2015) Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF165b Isoform in the Vitreous of Patients with Retinopathy of Prematurity. 128(18), 2505-2509.

Helen Mintz-Hittner, Kathleen Kennedy, Alice Chuang (2011) Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity. 364(7), 603-615.

Ilya Leskov, Shizuo Mukai (2015) Laser Therapy Versus Anti-VEGF Agents for Treatment of Retinopathy of Prematurity. 55(4), 81-90.

Norman Ashton (1970) RETINAL ANGIOGENESIS IN THE HUMAN EMBRYO. 26(2), 103-106.

A Hellström, L Smith, O Dammann (2013) Retinopathy of prematurity. 382, 1445-1457.

M Hartnett, John Penn (2012) Mechanisms and Management of Retinopathy of Prematurity. 367(26), 2515-2526.

Jing Chen, Lois Smith (2007) Retinopathy of prematurity. 10(2), 133-140.

(2010) Neuroscience Research Support at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Carlo Finer, N Walsh, M Rich, W Gantz, M (2010) Target ranges of oxygen saturation in extremely preterm infants. 362, 1959-1969.

B Australia, W Tarnow-Mordi, B Stenson (2016) Outcomes of Two Trials of Oxygen-Saturation Targets in Preterm Infants. 374(8), 749-760.

Carlo Finer, N Walsh, M (2010) Target Ranges of Oxygen Saturation in Extremely Preterm Infants. 362(21), 1959-1969.

Biukc Group, Biac Group, Binzc; Group, B Stenson, Tarnow-Mordi Wo, B Darlow (2013) Oxygen Saturation and Outcomes in Preterm Infants. 368(22), 2094-2104.

Barbara Schmidt, Robin Whyte, Elizabeth Asztalos, Diane Moddemann, Christian Poets, Yacov Rabi, Alfonso Solimano, Robin Roberts, For Canadian Oxygen Trial (cot) Group (2013) Effects of Targeting Higher vs Lower Arterial Oxygen Saturations on Death or Disability in Extremely Preterm Infants. 309(20), 2111.

Domenico Lepore, Fernando Molle, Monica Pagliara, Antonio Baldascino, Carmine Angora, Maria Sammartino, Graham Quinn (2011) Atlas of Fluorescein Angiographic Findings in Eyes Undergoing Laser for Retinopathy of Prematurity. 118(1), 168-175.

(2005) International Committee for the Classification of Retinopathy of Prematurity. 123, 991-999.

Capone Jr, A Ells, A Fielder, A (2006) Standard image of plus disease in retinopathy of prematurity. 124(11), 1669-e1670.

Kimberly Drenser, Michael Trese, Antonio Capone (2010) AGGRESSIVE POSTERIOR RETINOPATHY OF PREMATURITY. 30(4), S37-S40.

(2003) Revised Indications for the Treatment of Retinopathy of Prematurity. 121(12), 1684.

John Flynn, Tailoi Chan-Ling (2006) Retinopathy of Prematurity: Two Distinct Mechanisms That Underlie Zone 1 and Zone 2 Disease. 142(1), 46-59.e2.

Andreas Stahl, Domenico Lepore, Alistair Fielder, Brian Fleck, James Reynolds, Michael Chiang, Jun Li, Melissa Liew, Rainer Maier, Qi Zhu, Neil Marlow (2019) Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. 394(10208), 1551-1559.

Andree Henaine-Berra, Gerardo Garcia-Aguirre, Hugo Quiroz-Mercado, Maria Martinez-Castellanos (2014) Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy. 18(2), 120-123.

W Wu, P Yeh, S Chen (2011) Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in Taiwan. 118, 176-183.

Ruth Axer-Siegel, Moshe Snir, Yonina Ron, Ronit Friling, Lea Sirota, Dov Weinberger (2011) INTRAVITREAL BEVACIZUMAB AS SUPPLEMENTAL TREATMENT OR MONOTHERAPY FOR SEVERE RETINOPATHY OF PREMATURITY. 31(7), 1239-1247.

Wei-Chi Wu, Hsi-Kung Kuo, Po-Ting Yeh, Chung-May Yang, Chi-Chun Lai, San-Ni Chen (2013) An Updated Study of the Use of Bevacizumab in the Treatment of Patients with Prethreshold Retinopathy of Prematurity in Taiwan. 155(1), 150-158.e1.

B Harder, Von Baltz, S Jonas, J (2014) Intravitreal low-dosage bevacizumab for retinopathy of prematurity. 92, 577-581.

Huseyin Yetik, Murat Gunay, Sarkis Sirop, Ziya Salihoglu (2015) Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity - 27 month follow-up results from Turkey. 253(10), 1677-1683.

Qiujing Huang, Qi Zhang, Ping Fei, Yu Xu, Jiao Lyu, Xunda Ji, Jie Peng, Yi-An Li, Peiquan Zhao (2017) Ranibizumab Injection as Primary Treatment in Patients with Retinopathy of Prematurity. 124(8), 1156-1164.

David Wallace, Raymond Kraker, Sharon Freedman, Eric Crouch, Amy Hutchinson, Amit Bhatt, David Rogers, Michael Yang, Kathryn Haider, Deborah Vanderveen, R Siatkowski, Trevano Dean, Roy Beck, Michael Repka, Lois Smith, William Good, Mary Hartnett, Lingkun Kong, Jonathan Holmes (2017) Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity. 135(6), 654.

San-Ni Chen, Iebin Lian, Ya-Chi Hwang, Yi-Hsing Chen, Yao-Chung Chang, Kun-Hsien Lee, Chih-Chun Chuang, Wei-Chi Wu (2015) INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR RETINOPATHY OF PREMATURITY. 35(4), 667-674.

J Chhablani, P Rani, D Balakrishnan (2014) Unusual adverse choroidal reaction to intravitreal bevacizumab in aggressive posterior retinopathy of prematurity: the Indian Twin Cities ROP Screening (ITCROPS) data base report number 7. 29, 222-225.

K Falavarjani, Q Nguyen (2013) Adverse events and complications associated with intravitreal injection of anti-VEGF agents: A review of the literature. 27, 787-794.

David Wallace, Trevano Dean, Mary Hartnett, Lingkun Kong, Lois Smith, G Hubbard, Mary Mcgregor, Catherine Jordan, Iason Mantagos, Edward Bell, Raymond Kraker (2018) A Dosing Study of Bevacizumab for Retinopathy of Prematurity. 125(12), 1961-1966.

Odalis Arámbulo, Gabriel Dib, Juan Iturralde, Miguel Brito, João Fortes Filho (2018) Analysis of the Recurrence of Plus Disease after Intravitreal Ranibizumab as a Primary Monotherapy for Severe Retinopathy of Prematurity. 2(8), 858-863.

Ying Zhou, Yanrong Jiang, Yujing Bai, Jing Wen, Li Chen (2016) Vascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumab. 254(1), 31-36.

Muhammet Erol, Deniz Coban, Esin Sari, Ahmet Bilgin, Berna Dogan, Ozdemir Ozdemir, Zuhal Tunay (2015) Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity. 78(6), 340-343.

M Menke, C Framme, M Nelle (2015) Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease. 15, 20.

Subhadra Jalali, Divya Balakrishnan, Zarifa Zeynalova, Tapas Padhi, Padmaja Rani (2013) Serious adverse events and visual outcomes of rescue therapy using adjunct bevacizumab to laser and surgery for retinopathy of prematurity. The Indian Twin Cities Retinopathy of Prematurity Screening database Report number 5. 98(4), F327-F333.

V Compernolle, K Brusselmans, T Acker (2002) Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. 8, 702-710.

A Oconnor, T Stephenson, Johnson Tobin, M Ratib, S Moseley, M (2004) Visual function in low birthweight children. 88(9), 1149-1153.

Eva Larsson, Lene Martin, Gerd Holmström (2004) Peripheral and Central Visual Fields in 11-Year-Old Children Who Had Been Born Prematurely and At Term. 41(1), 39-45.

A Fielder, G Quinn (1997) Myopia of prematurity: nature, nurture, or disease?. 81(1), 2-3.

G Holmstrom, A Rydberg, E Larsson (2006) Prevalence and Development of Strabismus in 10-Year-Old Premature Children: A Population-Based Study. 43(6), 346-352.

Michelle Loeliger, Jhodie Duncan, Megan Cock, Richard Harding, Sandra Rees (2007) Vulnerability of Dopaminergic Amacrine Cells and Optic Nerve Myelination to Prenatal Endotoxin Exposure. 48(1), 472.

E Larsson, A Rydberg, G Holmstrom (2006) Contrast sensitivity in 10 year old preterm and full term children: a population based study. 90(1), 87-90.

Young Yu, Seong-Joon Kim, So Kim, Ho Choung, Gyu Park, Jang Heo (2006) Lens-sparing Vitrectomy for Stage 4 and Stage 5 Retinopathy of Prematurity. 20(2), 113.

Ehab El Rayes, Anand Vinekar, Antonio Capone (2008) THREE-YEAR ANATOMIC AND VISUAL OUTCOMES AFTER VITRECTOMY FOR STAGE 4B RETINOPATHY OF PREMATURITY. 28(4), 568-572.

Hiroyuki Kondo, Naoko Arita, Masahiko Osato, Hideyuki Hayashi, Kenji Oshima, Eiichi Uchio (2009) Late Recurrence of Retinal Detachment Following Successful Vitreous Surgery for Stages 4B and 5 Retinopathy of Prematurity. 147(4), 661-666.e1.